Lidonair Spray is a topical anesthetic formulation containing Lidocaine 7.5 mg and Prilocaine 2.5 mg per dose, designed to provide rapid and effective local anesthesia. The combination of these two amide-type local anesthetics offers a synergistic effect, resulting in enhanced numbing action with a rapid onset and prolonged duration. Lidonair Spray is indicated for use in minor surgical procedures, dermatological interventions, and other situations requiring temporary surface anesthesia to reduce pain and discomfort. Upon application, the active ingredients penetrate the skin to block nerve signal transmission, thereby diminishing sensation in the targeted area. This product is particularly useful for procedures such as venipuncture, superficial skin biopsies, laser treatments, and minor dermatologic surgeries. Lidonair Spray should be applied to intact skin only, avoiding mucous membranes and open wounds, and used according to the prescribed dosage to minimize the risk of systemic toxicity. It is contraindicated in patients with known hypersensitivity to amide anesthetics. Adverse effects are generally mild and may include localized erythema, edema, or transient burning sensation at the application site. Proper usage and adherence to guidelines ensure effective anesthesia with a favorable safety profile.